HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.

AbstractActivation of the nuclear factor (NF)-kappaB signaling pathway may be associated with the development of cardiac hypertrophy and its transition to heart failure (HF). The transgenic Myo-Tg mouse develops hypertrophy and HF as a result of overexpression of myotrophin in the heart associated with an elevated level of NF-kappaB activity. Using this mouse model and an NF-kappaB-targeted gene array, we first determined the components of NF-kappaB signaling cascade and the NF-kappaB-linked genes that are expressed during the progression to cardiac hypertrophy and HF. Second, we explored the effects of inhibition of NF-kappaB signaling events by using a gene knockdown approach: RNA interference through delivery of a short hairpin RNA against NF-kappaB p65 using a lentiviral vector (L-sh-p65). When the short hairpin RNA was delivered directly into the hearts of 10-week-old Myo-Tg mice, there was a significant regression of cardiac hypertrophy, associated with a significant reduction in NF-kappaB activation and atrial natriuretic factor expression. Our data suggest, for the first time, that inhibition of NF-kappaB using direct gene delivery of sh-p65 RNA results in regression of cardiac hypertrophy. These data validate NF-kappaB as a therapeutic target to prevent hypertrophy/HF.
AuthorsSudhiranjan Gupta, David Young, Ratan K Maitra, Anasuya Gupta, Zoran B Popovic, Sandro L Yong, Anjuli Mahajan, Qing Wang, Subha Sen (Affiliation: Department of Molecular Cardiology, Lerner Research Institute, NB50, The Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195, USA.)
JournalJournal of molecular biology (J Mol Biol) Vol. 375 Issue 3 Pg. 637-49 (Jan 18 2008) ISSN: 1089-8638 [Electronic] England
PMID18037434 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Fluorescent Dyes
  • Indoles
  • Intercellular Signaling Peptides and Proteins
  • NF-kappa B
  • RNA, Messenger
  • RNA, Small Interfering
  • Rela protein, mouse
  • Transcription Factor RelA
  • Xanthenes
  • myotrophin
  • Fluorescein-5-isothiocyanate
  • DAPI
  • Texas red
  • Ikbkb protein, mouse
  • I-kappa B Kinase
Topics
  • Aging (physiology)
  • Animals
  • Cardiomegaly (genetics, prevention & control)
  • Disease Progression
  • Female
  • Fluorescein-5-isothiocyanate
  • Fluorescent Dyes
  • Gene Silencing
  • Heart Failure (genetics, prevention & control)
  • I-kappa B Kinase (genetics, metabolism)
  • Indoles
  • Intercellular Signaling Peptides and Proteins (genetics, metabolism)
  • Male
  • Mice
  • Mice, Transgenic
  • Microscopy, Fluorescence
  • NF-kappa B (genetics, metabolism)
  • Organ Specificity (genetics)
  • RNA Interference
  • RNA, Messenger (metabolism)
  • RNA, Small Interfering (metabolism)
  • Time Factors
  • Transcription Factor RelA (genetics, metabolism)
  • Xanthenes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD